Atria Wealth Solutions’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$294K Sell
6,090
-57,180
-90% -$2.44M 0.01% 1163
2025
Q1
$2.53M Sell
63,270
-1,032
-2% -$46.7K 0.03% 551
2024
Q4
$2.97M Sell
64,302
-1,169
-2% -$53K 0.03% 507
2024
Q3
$2.8M Buy
65,471
+43
+0.1% +$1.78K 0.03% 516
2024
Q2
$2.78M Buy
65,428
+7,209
+12% +$285K 0.03% 520
2024
Q1
$2.24M Sell
58,219
-7,777
-12% -$281K 0.03% 593
2023
Q4
$2.2M Buy
65,996
+5,727
+10% +$176K 0.03% 576
2023
Q3
$1.75M Buy
60,269
+4,757
+9% +$143K 0.02% 608
2023
Q2
$1.65M Buy
55,512
+284
+0.5% +$7.62K 0.02% 639
2023
Q1
$1.41M Buy
55,228
+8,371
+18% +$198K 0.02% 678
2022
Q4
$988K Buy
+46,857
New +$1.03M 0.02% 755

Other funds holding FBCG

Atria Wealth Solutions's FBCG Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Fidelity Blue Chip Growth ETF (FBCG) stake by 90% in Q2 2025, selling an estimated $2.44M and leaving 6,090 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #1163.

Atria Wealth Solutions first reported a position in FBCG in Q4 2022 and has held it in 11 quarters since. The position peaked at $2.97M in Q4 2024. 200 funds tracked by Wall St. Rank hold FBCG as of Q2 2025.

  • Atria Wealth Solutions held 6,090 shares of Fidelity Blue Chip Growth ETF worth $294K as of Q2 2025.
  • Atria Wealth Solutions sold 57,180 Fidelity Blue Chip Growth ETF shares in Q2 2025, an estimated $2.44M.
  • Fidelity Blue Chip Growth ETF made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1163 holding.
  • Atria Wealth Solutions first reported a position in Fidelity Blue Chip Growth ETF in Q4 2022 and has held it in 11 quarters since.
  • Atria Wealth Solutions's Fidelity Blue Chip Growth ETF position peaked at $2.97M in Q4 2024.
  • 200 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.